Sponsored Ad | Levenstein Crypto Conference - Leaderboard

Chinese biopharma firm Atom Bioscience snaps over $82m in Series D round

Chinese biopharma firm Atom Bioscience snaps over $82m in Series D round

Image from Unsplash.

Biopharmaceutical firm Jiangsu Atom Bioscience and Pharmaceutical, which engages in new drug discovery and development to treat inflammatory and metabolic diseases, has bagged 600 million yuan ($82.8 million) in a Series D funding round.

Edited by: Joymitra Rai

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter